Timothy J. Sangiovanni's most recent trade in Zevra Therapeutics Inc was a trade of 3,000 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Finance & Corp Controller | Sale of securities on an exchange or to another person at price $ 7.86 per share. | 13 Feb 2025 | 3,000 | 16,341 (0%) | 0% | 7.9 | 23,588 | Common Stock |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Finance & Corp Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 38,000 | 38,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Finance & Corp Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Finance & Corp Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 11,666 | 23,334 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Finance & Corp Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2025 | 11,666 | 19,341 (0%) | 0% | - | Common Stock | |
| Zevra Therapeutics Inc | Sangiovanni Timothy J. | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 35,000 | 35,000 | - | - | Restricted Stock Unit | |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Corporate Controller | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 10 Mar 2023 | 1,100 | 4,349 (0%) | 0% | 4.1 | 4,554 | Common Stock |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Corporate Controller | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 10 Mar 2023 | 100 | 4,449 (0%) | 0% | 4.1 | 414 | Common Stock |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | SVP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 136,986 | 136,986 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,092 | 50,092 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Timothy J. Sangiovanni | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 44,023 | 44,023 | - | - | Stock Option (right to buy) |